I'm kinda undecided on whether or not more pr's are needed at this point. I understand the frustration with the share price but they have always released meaningful info when it comes about.
That's why I laugh when people call this a P&D. The people running this company are the furthest from pumping it.
I'm not sure what information people think they are holding back. If they are still fine tuning the release with Mediq, still trying to protect their IP, still conducting testing, still signing distribution deals, etc. what will they actually going to say in their pr's?
"Just wanted to let everyone know we are still working on things" will not raise the stock price.
It will come soon, just hang in there...
Market Data 
Markets 
AI
